Bosco Shang Wang

531 total citations
38 papers, 422 citations indexed

About

Bosco Shang Wang is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Bosco Shang Wang has authored 38 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Immunology and 8 papers in Cancer Research. Recurrent topics in Bosco Shang Wang's work include Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (9 papers) and RNA Interference and Gene Delivery (7 papers). Bosco Shang Wang is often cited by papers focused on Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (9 papers) and RNA Interference and Gene Delivery (7 papers). Bosco Shang Wang collaborates with scholars based in United States, China and Netherlands. Bosco Shang Wang's co-authors include John A. Mannick, Jerome P. Richie, Gráinne McLoughlin, Frederick E. Durr, Yang‐I Lin, Renjie Zhang, I. C. Hart, Homayoun Sadeghi, Glenn Steele and Changxue Zheng and has published in prestigious journals such as Science, The Journal of Immunology and Cancer.

In The Last Decade

Bosco Shang Wang

37 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bosco Shang Wang United States 12 162 125 110 105 51 38 422
Hubertus Stockinger Germany 8 153 0.9× 208 1.7× 81 0.7× 54 0.5× 43 0.8× 9 441
Joern-Peter Halle Germany 12 351 2.2× 162 1.3× 82 0.7× 45 0.4× 28 0.5× 24 562
Alessandra Galetto Italy 14 215 1.3× 236 1.9× 182 1.7× 85 0.8× 23 0.5× 22 600
M Stefănescu Romania 11 174 1.1× 212 1.7× 114 1.0× 113 1.1× 40 0.8× 23 467
Weixin Lu United States 10 164 1.0× 225 1.8× 138 1.3× 97 0.9× 14 0.3× 13 499
Ian Daniels United Kingdom 15 204 1.3× 255 2.0× 130 1.2× 39 0.4× 37 0.7× 35 544
R. Eckerstorfer Austria 11 237 1.5× 63 0.5× 132 1.2× 23 0.2× 101 2.0× 16 561
Christine Pike France 5 314 1.9× 182 1.5× 146 1.3× 42 0.4× 23 0.5× 5 802
T Seguchi Japan 11 262 1.6× 84 0.7× 51 0.5× 66 0.6× 17 0.3× 16 418
Martha B. Reich United States 12 211 1.3× 62 0.5× 70 0.6× 25 0.2× 28 0.5× 15 403

Countries citing papers authored by Bosco Shang Wang

Since Specialization
Citations

This map shows the geographic impact of Bosco Shang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bosco Shang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bosco Shang Wang more than expected).

Fields of papers citing papers by Bosco Shang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bosco Shang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bosco Shang Wang. The network helps show where Bosco Shang Wang may publish in the future.

Co-authorship network of co-authors of Bosco Shang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Bosco Shang Wang. A scholar is included among the top collaborators of Bosco Shang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bosco Shang Wang. Bosco Shang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Bosco Shang, et al.. (1998). Augmentation of hormonal activities with antibodies from cattle immunized with a combination of synthetic and recombinant growth Hormone Peptide. Animal Biotechnology. 9(2). 121–133. 3 indexed citations
2.
Wang, Bosco Shang, et al.. (1996). Immunological effect of a synthetic growth hormone peptide on the growth performance in swine. Molecular Immunology. 33(7-8). 609–614. 8 indexed citations
3.
Sadeghi, Homayoun, et al.. (1994). Generation of Heterohybridomas Capable of Releasing Swine Monoclonal Antibody Specific to Porcine Growth Hormone. Hybridoma. 13(3). 237–240. 3 indexed citations
4.
Wang, Bosco Shang, Renjie Zhang, Constantin A. Bona, & Thomas M. Moran. (1994). Promotion of animal growth with a monoclonal anti-idiotype specific to anti-porcine growth hormone antibody. Molecular Immunology. 31(9). 651–656. 12 indexed citations
5.
Zhang, Renjie, et al.. (1994). Modulation of the Effectiveness of Growth Hormone with a Monoclonal Antibody. NeuroImmunoModulation. 1(6). 343–349. 2 indexed citations
6.
Wang, Bosco Shang, et al.. (1993). Effect of Murine Ascites on the Ability of Hybridoma Cells to Produce Antibody and Proliferate In Vitro. Hybridoma. 12(1). 127–133. 1 indexed citations
7.
Wang, Bosco Shang, et al.. (1993). Inhibitory effect of growth-enhancing antibody on the interaction between growth hormone and growth hormone binding protein. Molecular and Cellular Endocrinology. 92(2). 161–166. 14 indexed citations
8.
Wang, Bosco Shang, et al.. (1992). A proposed mechanism of action of a growth hormone-specific monoclonal antibody in the enhancement of hormonal activity. Molecular Immunology. 29(3). 313–317. 22 indexed citations
9.
Durr, Frederick E., et al.. (1991). The mechanism of action of a synthetic immunomodulator, 3,6-Bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246, 738), in natural killer cell activation in animals. International Journal of Immunopharmacology. 13(7). 913–921. 1 indexed citations
10.
Durr, Frederick E., et al.. (1991). Depression of cell‐mediated immunity in plasmacytoma‐bearing mice. Immunology and Cell Biology. 69(1). 11–16. 1 indexed citations
11.
Wang, Bosco Shang, et al.. (1989). Reconstitution of cytolytic alloreactivity with N-[4-[(4-fluorophenyl) sulfonyl]phenyl]acetamide (CL 259,763) in animals immunocompromised by cyclophosphamide. International Journal of Immunopharmacology. 11(5). 479–486. 3 indexed citations
12.
Wang, Bosco Shang, et al.. (1989). Internalization and shedding of Lym-1 monoclonal antibody following interaction with surface antigens of a cultured human B cell lymphoma. Cellular Immunology. 123(2). 283–293. 3 indexed citations
13.
Lin, Yang‐I, et al.. (1988). Low molecular weight immunopotentiators. International Journal of Immunopharmacology. 10(5). 497–510. 21 indexed citations
14.
Wang, Bosco Shang, et al.. (1987). Relationship of chemical structures of anthraquinones with their effects on the suppression of immune responses. International Journal of Immunopharmacology. 9(6). 733–739. 13 indexed citations
15.
Wang, Bosco Shang, et al.. (1987). Internalization and re-expression of antigens of human melanoma cells following exposure to monoclonal antibody. Cellular Immunology. 106(1). 12–21. 8 indexed citations
16.
Wang, Bosco Shang, et al.. (1982). Characterization of suppressor cells generated in mice after surgical trauma. Clinical Immunology and Immunopathology. 24(2). 161–170. 22 indexed citations
17.
18.
Wang, Bosco Shang, et al.. (1979). In vivo effects and parallel in vitro cytotoxicity of splenocytes harvested from treated or control C57BL/6J mice after adjuvant immunotherapy of pulmonary metastases using xenogeneic RNA specific to B16 murine melanoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39(5). 1702–7. 3 indexed citations
19.
Wang, Bosco Shang & John A. Mannick. (1979). Relationship between Lymphocyte Proliferation and Tumor-Specific Cytotoxicity after Immune RNA Treatment. The Journal of Immunology. 123(3). 1057–1061.
20.
Wang, Bosco Shang, et al.. (1978). Prevention of Death from Metastases by Immune RNA Therapy. Science. 202(4363). 59–60. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hubertus Stockinger Breakdown of academic impact, for papers by Joern-Peter Halle Breakdown of academic impact, for papers by Alessandra Galetto Breakdown of academic impact, for papers by M Stefănescu Breakdown of academic impact, for papers by Weixin Lu Breakdown of academic impact, for papers by Ian Daniels Breakdown of academic impact, for papers by R. Eckerstorfer Breakdown of academic impact, for papers by Christine Pike Breakdown of academic impact, for papers by T Seguchi Breakdown of academic impact, for papers by Martha B. Reich
Rankless by CCL
2026